Lowering n-6/n-3 Ratio as an Important Dietary Intervention to Prevent LPS-Inducible Dyslipidemia and Hepatic Abnormalities in ob/ob Mice
Obesity is closely associated with low-grade chronic and systemic inflammation and dyslipidemia, and the consumption of omega-3 polyunsaturated fatty acids (n-3 PUFAs) may modulate obesity-related disorders, such as inflammation and dyslipidemia. An emerging research question is to understand the di...
Gespeichert in:
Veröffentlicht in: | International journal of molecular sciences 2022-06, Vol.23 (12), p.6384 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | 12 |
container_start_page | 6384 |
container_title | International journal of molecular sciences |
container_volume | 23 |
creator | Park, Seohyun Lee, Jae-Joon Lee, Jisu Lee, Jennifer K. Byun, Jaemin Kim, Inyong Ha, Jung-Heun |
description | Obesity is closely associated with low-grade chronic and systemic inflammation and dyslipidemia, and the consumption of omega-3 polyunsaturated fatty acids (n-3 PUFAs) may modulate obesity-related disorders, such as inflammation and dyslipidemia. An emerging research question is to understand the dietary intervention strategy that is more important regarding n-3 PUFA consumption: (1) a lower ratio of n-6/n-3 PUFAs or (2) a higher amount of n-3 PUFAs consumption. To understand the desirable dietary intervention method of n-3 PUFAs consumption, we replaced lard from the experimental diets with either perilla oil (PO) or corn oil (CO) to have identical n-3 amounts in the experimental diets. PO had a lower n-6/n-3 ratio, whereas CO contained higher amounts of PUFAs; it inherently contained relatively lower n-3 but higher n-6 PUFAs than PO. After the 12-week dietary intervention in ob/ob mice, dyslipidemia was observed in the normal chow and CO-fed ob/ob mice; however, PO feeding increased the high density lipoprotein-cholesterol (HDL-C) level; further, not only did the HDL-C level increase, the low density lipoprotein-cholesterol (LDL-C) and triglyceride (TG) levels also decreased significantly after lipopolysaccharide (LPS) injection. Consequently, extra TG accumulated in the liver and white adipose tissue (WAT) of normal chow- or CO-fed ob/ob mice after LPS injection; however, PO consumption decreased serum TG accumulation in the liver and WAT. PUFAs replacement attenuated systemic inflammation induced by LPS injection by increasing anti-inflammatory cytokines but inhibiting pro-inflammatory cytokine production in the serum and WAT. PO further decreased hepatic inflammation and fibrosis in comparison with the ND and CO. Hepatic functional biomarkers (aspartate aminotransferase (AST) and alanine transaminase (ALT) levels) were also remarkably decreased in the PO group. In LPS-challenged ob/ob mice, PO and CO decreased adipocyte size and adipokine secretion, with a reduction in phosphorylation of MAPKs compared to the ND group. In addition, LPS-inducible endoplasmic reticulum (ER) and oxidative stress decreased with consumption of PUFAs. Taken together, PUFAs from PO and CO play a role in regulating obesity-related disorders. Moreover, PO, which possesses a lower ratio of n-6/n-3 PUFAs, remarkably alleviated metabolic dysfunction in LPS-induced ob/ob mice. Therefore, an interventional trial considering the ratio of n-6/n-3 PUFAs may be desirable for modulating |
doi_str_mv | 10.3390/ijms23126384 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9224551</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2681038861</sourcerecordid><originalsourceid>FETCH-LOGICAL-c455t-698648290609407d95590e8a4b4958aacf63c6a1e8e080500b3f04f6b52b96f43</originalsourceid><addsrcrecordid>eNpdkctu1TAQhiMEohfY8QCW2LAgHMe32BukqoX2SAdRcVlbtjMpPkrsYDtFfQTeGh-1QoXVzGg-ffpH0zSvOvyOUoU3fj9nQjsiqGRPmuOOEdJiLPqnj_qj5iTnPcaEEq6eN0eU94xIoo6b37v4C5IPNyi0YhNair6Y4iMyGZmAtvMSUzGhoAsPxaQ7tA0F0i2EygRUIrpOcJjQ7vpruw3D6rydAF3c5ckvfoDZm-oZ0BUsVevQmQ0xzWbyxUNGPqBoN9GiT97Bi-bZaKYMLx_qafP944dv51ft7vPl9vxs1zrGeWmFkoLV6FhgxXA_KM4VBmmYZYpLY9woqBOmAwlYYo6xpSNmo7CcWCVGRk-b9_feZbUzDK6mT2bSS_JzPVBH4_W_m-B_6Jt4qxUhNUFXBW8eBCn-XCEXPfvsYJpMgLhmTYTsMJVSHNDX_6H7uKZQz6tUr3pOeUcq9faecinmnGD8G6bD-vBj_fjH9A-AfZiL</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2679753512</pqid></control><display><type>article</type><title>Lowering n-6/n-3 Ratio as an Important Dietary Intervention to Prevent LPS-Inducible Dyslipidemia and Hepatic Abnormalities in ob/ob Mice</title><source>PubMed (Medline)</source><source>MDPI - Multidisciplinary Digital Publishing Institute</source><source>EZB Electronic Journals Library</source><creator>Park, Seohyun ; Lee, Jae-Joon ; Lee, Jisu ; Lee, Jennifer K. ; Byun, Jaemin ; Kim, Inyong ; Ha, Jung-Heun</creator><creatorcontrib>Park, Seohyun ; Lee, Jae-Joon ; Lee, Jisu ; Lee, Jennifer K. ; Byun, Jaemin ; Kim, Inyong ; Ha, Jung-Heun</creatorcontrib><description>Obesity is closely associated with low-grade chronic and systemic inflammation and dyslipidemia, and the consumption of omega-3 polyunsaturated fatty acids (n-3 PUFAs) may modulate obesity-related disorders, such as inflammation and dyslipidemia. An emerging research question is to understand the dietary intervention strategy that is more important regarding n-3 PUFA consumption: (1) a lower ratio of n-6/n-3 PUFAs or (2) a higher amount of n-3 PUFAs consumption. To understand the desirable dietary intervention method of n-3 PUFAs consumption, we replaced lard from the experimental diets with either perilla oil (PO) or corn oil (CO) to have identical n-3 amounts in the experimental diets. PO had a lower n-6/n-3 ratio, whereas CO contained higher amounts of PUFAs; it inherently contained relatively lower n-3 but higher n-6 PUFAs than PO. After the 12-week dietary intervention in ob/ob mice, dyslipidemia was observed in the normal chow and CO-fed ob/ob mice; however, PO feeding increased the high density lipoprotein-cholesterol (HDL-C) level; further, not only did the HDL-C level increase, the low density lipoprotein-cholesterol (LDL-C) and triglyceride (TG) levels also decreased significantly after lipopolysaccharide (LPS) injection. Consequently, extra TG accumulated in the liver and white adipose tissue (WAT) of normal chow- or CO-fed ob/ob mice after LPS injection; however, PO consumption decreased serum TG accumulation in the liver and WAT. PUFAs replacement attenuated systemic inflammation induced by LPS injection by increasing anti-inflammatory cytokines but inhibiting pro-inflammatory cytokine production in the serum and WAT. PO further decreased hepatic inflammation and fibrosis in comparison with the ND and CO. Hepatic functional biomarkers (aspartate aminotransferase (AST) and alanine transaminase (ALT) levels) were also remarkably decreased in the PO group. In LPS-challenged ob/ob mice, PO and CO decreased adipocyte size and adipokine secretion, with a reduction in phosphorylation of MAPKs compared to the ND group. In addition, LPS-inducible endoplasmic reticulum (ER) and oxidative stress decreased with consumption of PUFAs. Taken together, PUFAs from PO and CO play a role in regulating obesity-related disorders. Moreover, PO, which possesses a lower ratio of n-6/n-3 PUFAs, remarkably alleviated metabolic dysfunction in LPS-induced ob/ob mice. Therefore, an interventional trial considering the ratio of n-6/n-3 PUFAs may be desirable for modulating metabolic complications, such as inflammatory responses and ER stress in the circulation, liver, and/or WAT.</description><identifier>ISSN: 1422-0067</identifier><identifier>ISSN: 1661-6596</identifier><identifier>EISSN: 1422-0067</identifier><identifier>DOI: 10.3390/ijms23126384</identifier><identifier>PMID: 35742829</identifier><language>eng</language><publisher>Basel: MDPI AG</publisher><subject>Abnormalities ; Adipose tissue ; Alanine ; Alanine transaminase ; Animal models ; Aspartate aminotransferase ; Body mass index ; Carbon monoxide ; Cholesterol ; Cytokines ; Diet ; Dyslipidemia ; Endoplasmic reticulum ; Fatty acids ; Fibrosis ; Food ; High density lipoprotein ; Inflammation ; Injection ; Insulin resistance ; Levels ; Lipids ; Lipopolysaccharides ; Liver ; Low density lipoprotein ; Metabolic disorders ; Metabolism ; Obesity ; Overweight ; Oxidative stress ; Phosphorylation ; Physiology ; Polyunsaturated fatty acids ; Transaminase ; Triglycerides</subject><ispartof>International journal of molecular sciences, 2022-06, Vol.23 (12), p.6384</ispartof><rights>2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2022 by the authors. 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c455t-698648290609407d95590e8a4b4958aacf63c6a1e8e080500b3f04f6b52b96f43</citedby><cites>FETCH-LOGICAL-c455t-698648290609407d95590e8a4b4958aacf63c6a1e8e080500b3f04f6b52b96f43</cites><orcidid>0000-0001-5737-612X ; 0000-0002-3327-1945 ; 0000-0002-2196-7339 ; 0000-0001-5282-531X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9224551/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9224551/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,724,777,781,882,27905,27906,53772,53774</link.rule.ids></links><search><creatorcontrib>Park, Seohyun</creatorcontrib><creatorcontrib>Lee, Jae-Joon</creatorcontrib><creatorcontrib>Lee, Jisu</creatorcontrib><creatorcontrib>Lee, Jennifer K.</creatorcontrib><creatorcontrib>Byun, Jaemin</creatorcontrib><creatorcontrib>Kim, Inyong</creatorcontrib><creatorcontrib>Ha, Jung-Heun</creatorcontrib><title>Lowering n-6/n-3 Ratio as an Important Dietary Intervention to Prevent LPS-Inducible Dyslipidemia and Hepatic Abnormalities in ob/ob Mice</title><title>International journal of molecular sciences</title><description>Obesity is closely associated with low-grade chronic and systemic inflammation and dyslipidemia, and the consumption of omega-3 polyunsaturated fatty acids (n-3 PUFAs) may modulate obesity-related disorders, such as inflammation and dyslipidemia. An emerging research question is to understand the dietary intervention strategy that is more important regarding n-3 PUFA consumption: (1) a lower ratio of n-6/n-3 PUFAs or (2) a higher amount of n-3 PUFAs consumption. To understand the desirable dietary intervention method of n-3 PUFAs consumption, we replaced lard from the experimental diets with either perilla oil (PO) or corn oil (CO) to have identical n-3 amounts in the experimental diets. PO had a lower n-6/n-3 ratio, whereas CO contained higher amounts of PUFAs; it inherently contained relatively lower n-3 but higher n-6 PUFAs than PO. After the 12-week dietary intervention in ob/ob mice, dyslipidemia was observed in the normal chow and CO-fed ob/ob mice; however, PO feeding increased the high density lipoprotein-cholesterol (HDL-C) level; further, not only did the HDL-C level increase, the low density lipoprotein-cholesterol (LDL-C) and triglyceride (TG) levels also decreased significantly after lipopolysaccharide (LPS) injection. Consequently, extra TG accumulated in the liver and white adipose tissue (WAT) of normal chow- or CO-fed ob/ob mice after LPS injection; however, PO consumption decreased serum TG accumulation in the liver and WAT. PUFAs replacement attenuated systemic inflammation induced by LPS injection by increasing anti-inflammatory cytokines but inhibiting pro-inflammatory cytokine production in the serum and WAT. PO further decreased hepatic inflammation and fibrosis in comparison with the ND and CO. Hepatic functional biomarkers (aspartate aminotransferase (AST) and alanine transaminase (ALT) levels) were also remarkably decreased in the PO group. In LPS-challenged ob/ob mice, PO and CO decreased adipocyte size and adipokine secretion, with a reduction in phosphorylation of MAPKs compared to the ND group. In addition, LPS-inducible endoplasmic reticulum (ER) and oxidative stress decreased with consumption of PUFAs. Taken together, PUFAs from PO and CO play a role in regulating obesity-related disorders. Moreover, PO, which possesses a lower ratio of n-6/n-3 PUFAs, remarkably alleviated metabolic dysfunction in LPS-induced ob/ob mice. Therefore, an interventional trial considering the ratio of n-6/n-3 PUFAs may be desirable for modulating metabolic complications, such as inflammatory responses and ER stress in the circulation, liver, and/or WAT.</description><subject>Abnormalities</subject><subject>Adipose tissue</subject><subject>Alanine</subject><subject>Alanine transaminase</subject><subject>Animal models</subject><subject>Aspartate aminotransferase</subject><subject>Body mass index</subject><subject>Carbon monoxide</subject><subject>Cholesterol</subject><subject>Cytokines</subject><subject>Diet</subject><subject>Dyslipidemia</subject><subject>Endoplasmic reticulum</subject><subject>Fatty acids</subject><subject>Fibrosis</subject><subject>Food</subject><subject>High density lipoprotein</subject><subject>Inflammation</subject><subject>Injection</subject><subject>Insulin resistance</subject><subject>Levels</subject><subject>Lipids</subject><subject>Lipopolysaccharides</subject><subject>Liver</subject><subject>Low density lipoprotein</subject><subject>Metabolic disorders</subject><subject>Metabolism</subject><subject>Obesity</subject><subject>Overweight</subject><subject>Oxidative stress</subject><subject>Phosphorylation</subject><subject>Physiology</subject><subject>Polyunsaturated fatty acids</subject><subject>Transaminase</subject><subject>Triglycerides</subject><issn>1422-0067</issn><issn>1661-6596</issn><issn>1422-0067</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNpdkctu1TAQhiMEohfY8QCW2LAgHMe32BukqoX2SAdRcVlbtjMpPkrsYDtFfQTeGh-1QoXVzGg-ffpH0zSvOvyOUoU3fj9nQjsiqGRPmuOOEdJiLPqnj_qj5iTnPcaEEq6eN0eU94xIoo6b37v4C5IPNyi0YhNair6Y4iMyGZmAtvMSUzGhoAsPxaQ7tA0F0i2EygRUIrpOcJjQ7vpruw3D6rydAF3c5ckvfoDZm-oZ0BUsVevQmQ0xzWbyxUNGPqBoN9GiT97Bi-bZaKYMLx_qafP944dv51ft7vPl9vxs1zrGeWmFkoLV6FhgxXA_KM4VBmmYZYpLY9woqBOmAwlYYo6xpSNmo7CcWCVGRk-b9_feZbUzDK6mT2bSS_JzPVBH4_W_m-B_6Jt4qxUhNUFXBW8eBCn-XCEXPfvsYJpMgLhmTYTsMJVSHNDX_6H7uKZQz6tUr3pOeUcq9faecinmnGD8G6bD-vBj_fjH9A-AfZiL</recordid><startdate>20220607</startdate><enddate>20220607</enddate><creator>Park, Seohyun</creator><creator>Lee, Jae-Joon</creator><creator>Lee, Jisu</creator><creator>Lee, Jennifer K.</creator><creator>Byun, Jaemin</creator><creator>Kim, Inyong</creator><creator>Ha, Jung-Heun</creator><general>MDPI AG</general><general>MDPI</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-5737-612X</orcidid><orcidid>https://orcid.org/0000-0002-3327-1945</orcidid><orcidid>https://orcid.org/0000-0002-2196-7339</orcidid><orcidid>https://orcid.org/0000-0001-5282-531X</orcidid></search><sort><creationdate>20220607</creationdate><title>Lowering n-6/n-3 Ratio as an Important Dietary Intervention to Prevent LPS-Inducible Dyslipidemia and Hepatic Abnormalities in ob/ob Mice</title><author>Park, Seohyun ; Lee, Jae-Joon ; Lee, Jisu ; Lee, Jennifer K. ; Byun, Jaemin ; Kim, Inyong ; Ha, Jung-Heun</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c455t-698648290609407d95590e8a4b4958aacf63c6a1e8e080500b3f04f6b52b96f43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Abnormalities</topic><topic>Adipose tissue</topic><topic>Alanine</topic><topic>Alanine transaminase</topic><topic>Animal models</topic><topic>Aspartate aminotransferase</topic><topic>Body mass index</topic><topic>Carbon monoxide</topic><topic>Cholesterol</topic><topic>Cytokines</topic><topic>Diet</topic><topic>Dyslipidemia</topic><topic>Endoplasmic reticulum</topic><topic>Fatty acids</topic><topic>Fibrosis</topic><topic>Food</topic><topic>High density lipoprotein</topic><topic>Inflammation</topic><topic>Injection</topic><topic>Insulin resistance</topic><topic>Levels</topic><topic>Lipids</topic><topic>Lipopolysaccharides</topic><topic>Liver</topic><topic>Low density lipoprotein</topic><topic>Metabolic disorders</topic><topic>Metabolism</topic><topic>Obesity</topic><topic>Overweight</topic><topic>Oxidative stress</topic><topic>Phosphorylation</topic><topic>Physiology</topic><topic>Polyunsaturated fatty acids</topic><topic>Transaminase</topic><topic>Triglycerides</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Park, Seohyun</creatorcontrib><creatorcontrib>Lee, Jae-Joon</creatorcontrib><creatorcontrib>Lee, Jisu</creatorcontrib><creatorcontrib>Lee, Jennifer K.</creatorcontrib><creatorcontrib>Byun, Jaemin</creatorcontrib><creatorcontrib>Kim, Inyong</creatorcontrib><creatorcontrib>Ha, Jung-Heun</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest Research Library</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>International journal of molecular sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Park, Seohyun</au><au>Lee, Jae-Joon</au><au>Lee, Jisu</au><au>Lee, Jennifer K.</au><au>Byun, Jaemin</au><au>Kim, Inyong</au><au>Ha, Jung-Heun</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Lowering n-6/n-3 Ratio as an Important Dietary Intervention to Prevent LPS-Inducible Dyslipidemia and Hepatic Abnormalities in ob/ob Mice</atitle><jtitle>International journal of molecular sciences</jtitle><date>2022-06-07</date><risdate>2022</risdate><volume>23</volume><issue>12</issue><spage>6384</spage><pages>6384-</pages><issn>1422-0067</issn><issn>1661-6596</issn><eissn>1422-0067</eissn><abstract>Obesity is closely associated with low-grade chronic and systemic inflammation and dyslipidemia, and the consumption of omega-3 polyunsaturated fatty acids (n-3 PUFAs) may modulate obesity-related disorders, such as inflammation and dyslipidemia. An emerging research question is to understand the dietary intervention strategy that is more important regarding n-3 PUFA consumption: (1) a lower ratio of n-6/n-3 PUFAs or (2) a higher amount of n-3 PUFAs consumption. To understand the desirable dietary intervention method of n-3 PUFAs consumption, we replaced lard from the experimental diets with either perilla oil (PO) or corn oil (CO) to have identical n-3 amounts in the experimental diets. PO had a lower n-6/n-3 ratio, whereas CO contained higher amounts of PUFAs; it inherently contained relatively lower n-3 but higher n-6 PUFAs than PO. After the 12-week dietary intervention in ob/ob mice, dyslipidemia was observed in the normal chow and CO-fed ob/ob mice; however, PO feeding increased the high density lipoprotein-cholesterol (HDL-C) level; further, not only did the HDL-C level increase, the low density lipoprotein-cholesterol (LDL-C) and triglyceride (TG) levels also decreased significantly after lipopolysaccharide (LPS) injection. Consequently, extra TG accumulated in the liver and white adipose tissue (WAT) of normal chow- or CO-fed ob/ob mice after LPS injection; however, PO consumption decreased serum TG accumulation in the liver and WAT. PUFAs replacement attenuated systemic inflammation induced by LPS injection by increasing anti-inflammatory cytokines but inhibiting pro-inflammatory cytokine production in the serum and WAT. PO further decreased hepatic inflammation and fibrosis in comparison with the ND and CO. Hepatic functional biomarkers (aspartate aminotransferase (AST) and alanine transaminase (ALT) levels) were also remarkably decreased in the PO group. In LPS-challenged ob/ob mice, PO and CO decreased adipocyte size and adipokine secretion, with a reduction in phosphorylation of MAPKs compared to the ND group. In addition, LPS-inducible endoplasmic reticulum (ER) and oxidative stress decreased with consumption of PUFAs. Taken together, PUFAs from PO and CO play a role in regulating obesity-related disorders. Moreover, PO, which possesses a lower ratio of n-6/n-3 PUFAs, remarkably alleviated metabolic dysfunction in LPS-induced ob/ob mice. Therefore, an interventional trial considering the ratio of n-6/n-3 PUFAs may be desirable for modulating metabolic complications, such as inflammatory responses and ER stress in the circulation, liver, and/or WAT.</abstract><cop>Basel</cop><pub>MDPI AG</pub><pmid>35742829</pmid><doi>10.3390/ijms23126384</doi><orcidid>https://orcid.org/0000-0001-5737-612X</orcidid><orcidid>https://orcid.org/0000-0002-3327-1945</orcidid><orcidid>https://orcid.org/0000-0002-2196-7339</orcidid><orcidid>https://orcid.org/0000-0001-5282-531X</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1422-0067 |
ispartof | International journal of molecular sciences, 2022-06, Vol.23 (12), p.6384 |
issn | 1422-0067 1661-6596 1422-0067 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9224551 |
source | PubMed (Medline); MDPI - Multidisciplinary Digital Publishing Institute; EZB Electronic Journals Library |
subjects | Abnormalities Adipose tissue Alanine Alanine transaminase Animal models Aspartate aminotransferase Body mass index Carbon monoxide Cholesterol Cytokines Diet Dyslipidemia Endoplasmic reticulum Fatty acids Fibrosis Food High density lipoprotein Inflammation Injection Insulin resistance Levels Lipids Lipopolysaccharides Liver Low density lipoprotein Metabolic disorders Metabolism Obesity Overweight Oxidative stress Phosphorylation Physiology Polyunsaturated fatty acids Transaminase Triglycerides |
title | Lowering n-6/n-3 Ratio as an Important Dietary Intervention to Prevent LPS-Inducible Dyslipidemia and Hepatic Abnormalities in ob/ob Mice |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T17%3A30%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Lowering%20n-6/n-3%20Ratio%20as%20an%20Important%20Dietary%20Intervention%20to%20Prevent%20LPS-Inducible%20Dyslipidemia%20and%20Hepatic%20Abnormalities%20in%20ob/ob%20Mice&rft.jtitle=International%20journal%20of%20molecular%20sciences&rft.au=Park,%20Seohyun&rft.date=2022-06-07&rft.volume=23&rft.issue=12&rft.spage=6384&rft.pages=6384-&rft.issn=1422-0067&rft.eissn=1422-0067&rft_id=info:doi/10.3390/ijms23126384&rft_dat=%3Cproquest_pubme%3E2681038861%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2679753512&rft_id=info:pmid/35742829&rfr_iscdi=true |